YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Obstetrics and Gynecology (산부인과학교실)

Dept. of Obstetrics and Gynecology (산부인과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

MicroRNA expression profiles in serous ovarian carcinoma

Eun Ji Nam ; Heejei Yoon ; Sang Wun Kim ; Hoguen Kim ; Young Tae Kim ; Jae Ho... CLINICAL CANCER RESEARCH, Vol.14(9) : 2690-2695, 2008
PDF Read more

Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial o...

HanByoul Cho ; Hye Won Hur ; Sang Wun Kim ; Sung Hoon Kim ; Jae Hoon Kim ; Yo... CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol.58(1) : 15-23, 2009
Read more

Osteopontin as apotential diagnostic biomarker for ovarian cancer

Jae Hoon Kim ; Steven J. Skates ; Toshimitsu Uede ; Kwong Kwok Wong ; John O.... JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol.287(13) : 1671-1679, 2002
Read more
This table browses all dspace content
Issue DateTitleJournal Title
2025Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression CANCER GENOMICS & PROTEOMICS
2025PM exposure during pregnancy affects childhood asthma via placental epigenetic changes: Neuronal differentiation and proliferation and Notch signaling pathwaysENVIRONMENTAL POLLUTION
2025The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer CANCERS
2025Exploring the characteristics of immortalized human ovarian surface epithelial cell lines HELIYON
2025Handgrip strength and diabetes in postmenopausal women: insights from the Korean National Health and Nutrition Examination Survey 2014-2019MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
2024Oral hormone replacement therapy and uterine volume in Korean adolescents with Turner syndrome: A retrospective case-control studyJOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY
2024Maternal and Neonatal Outcomes Based on Changes in Glycosylated Hemoglobin Levels During First and Second Trimesters of Pregnancy in Women with Pregestational Diabetes: Multicenter, Retrospective Cohort Study in South Korea Life
2024Decision-making process for risk-reducing salpingo-oophorectomy among Korean women with hereditary breast cancer: A grounded theory studyEUROPEAN JOURNAL OF ONCOLOGY NURSING
2024Factors affecting the technical outcome of catheter-directed sclerotherapy for ovarian endometriomasEUROPEAN JOURNAL OF RADIOLOGY
2024Pregnancy outcomes of cerclage in twin gestations: a multicenter retrospective cohort study JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
2024Clinicopathological Features and Oncological Outcomes of Germline Partner and Localizer of Breast Cancer 2-Mutated Breast Cancer in KoreaJOURNAL OF BREAST CANCER
2024Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer BMC CANCER
2024Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapyJOURNAL OF GYNECOLOGIC ONCOLOGY
2024Efficacy of large language models and their potential in Obstetrics and Gynecology education Obstetrics & Gynecology Science
2024Prognostic impact of intraoperative rupture in early-stage epithelial ovarian cancer: an ancillary study of GORILLA-3002EJSO
2024Prenatal Diagnosis and Clinical Outcomes of Isolated Mega Cisterna MagnaJOURNAL OF CHILD NEUROLOGY
2024Investigation of cell-to-cell transfer of polystyrene microplastics through extracellular vesicle-mediated communicationBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2024Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2024A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2024Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trialLANCET
1234567891011 84
  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links